October 14, 2026
  • October 14, 2026
  • Home
  • Grid Layout Two

Grid Layout Two

Pharma dealmaking recovers with PE push

by October 9, 2023 0

Consolidation and dealmaking activity are increasing in the Indian pharma sector as multinationals’ drug portfolios thin out and Indian promoters seek exits. Rising compliance costs and pricing pressures are leading to mergers and acquisitions, with high-leverage companies cashing out. Indian strategic buyers and private equity firms like KKR and Carlyle are actively acquiring domestic...

Read More